Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | NA |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.93 | 1.74 |
NAV | ₹14.44 | ₹82.07 |
Fund Started | 19 Feb 2019 | 17 Nov 2003 |
Fund Size | ₹26.20 Cr | ₹3406.09 Cr |
Exit Load | - | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.80% | 7.05% |
3 Year | 9.56% | 12.32% |
5 Year | 5.54% | 12.32% |
1 Year
3 Year
5 Year
Equity | 24.89% | 20.96% |
Cash | 5.79% | 3.94% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 2.23% |
ICICI Bank Ltd. | 1.93% |
Bajaj Finance Ltd. | 1.75% |
Bharti Airtel Ltd. | 1.06% |
Metropolis Healthcare Ltd. | 0.96% |
State Bank of India | 0.88% |
Fortis Healthcare Ltd. | 0.88% |
Max Financial Services Ltd. | 0.85% |
Hindalco Industries Ltd. | 0.85% |
Ultratech Cement Ltd. | 0.80% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.50% |
HDFC Bank Ltd. | 2.00% |
State Bank of India | 1.19% |
Axis Bank Ltd. | 1.14% |
Reliance Industries Ltd. | 1.04% |
Infosys Ltd. | 0.78% |
Larsen & Toubro Ltd. | 0.76% |
Bharti Airtel Ltd. | 0.76% |
ITC Ltd. | 0.74% |
Sun Pharmaceutical Industries Ltd. | 0.74% |
Name | Dhaval Joshi | Dhruv Muchhal |
Start Date | 21 Nov 2022 | 14 Sep 2023 |
Name
Start Date
Description | The Scheme seeks to invests predominantly in debt and money market instruments with marginal allocation to equity and equity related instruments. | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 19 Feb 2019 | 17 Nov 2003 |
Description
Launch Date